[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Iffat Anwar Medical Complex\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":90},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,42,65],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100562235","combined-photo-biomodulation-at-acupuncture-points-autologous-prp-and-umbilical-cord-derived-exosome-therapy-in-autism-spectrum-disorder-100562235",false,"NCT06600529","Combined Photo-Biomodulation At Acupuncture Points, Autologous PRP, and Umbilical Cord-Derived Exosome Therapy in Autism Spectrum Disorder","Evaluation of Combined Photo-Biomodulation At Acupuncture Points, Autologous PRP, and Umbilical Cord-Derived Exosome Therapy in Autism Spectrum Disorder: a Randomized Controlled Trial","Biomodulation","Inclusion Criteria:\n\n* • Diagnosis of Autism Spectrum Disorder based on DSM-5 criteria\n\n  * Age 3-12 years\n  * Stable on current medications for at least 4 weeks prior to study entry\n  * Parents or legal guardians willing to provide informed consent\n\nExclusion Criteria:\n\n* • Severe comorbid medical conditions\n\n  * Prior stem cell or exosome therapy\n  * History of hypersensitivity to any component of the interventions\n  * Inability to comply with study procedures","ALL","3 Years","12 Years",{"count":21,"type":22},100,"ESTIMATED","INTERVENTIONAL",[25],"NA","This randomized controlled trial aims to evaluate the efficacy of a combination of photo-biomodulation at acupuncture points, autologous platelet-rich plasma (PRP), and umbilical cord-derived exosome therapy in children with Autism Spectrum Disorder (ASD). The study will compare these interventions against standard care to determine their impact on the severity of autism symptoms, as measured by the Childhood Autism Rating Scale (CARS) and other related markers.",[28],"Autism Spectrum Disorder","RECRUITING","2024-09-16",{"date":32,"type":33},"2024-09-19","ACTUAL",{"date":35,"type":33},"2024-08-13",{"date":37,"type":22},"2025-12-13",{"name":39,"class":40},"Iffat Anwar Medical Complex","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":11,"sex":17,"minAge":50,"maxAge":51,"enrollmentInfo":52,"targetDuration":4,"studyType":23,"phases":53,"briefSummary":55,"conditions":56,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":41},"100556394","early-phase-1-pulsed-rf-neuromodulation-and-leukocyte-rich-prp-for-refractory-low-back-pain-100556394","NCT06524531","Pulsed RF Neuromodulation and Leukocyte-Rich PRP for Refractory Low Back Pain","Safety and Efficacy of Pulsed RF Neuromodulation and Leukocyte-Rich PRP for the Treatment of Refractory Low Back Pain Due to Multifidus Dysfunction","Multifidus","Inclusion Criteria:\n\n* Refractory low back pain due to multifidus dysfunction.\n* Pain persisting for more than 6 months despite conventional treatments.\n* Ability to provide informed consent.\n\nExclusion Criteria:\n\n* Previous spinal surgery within the last year.\n* Current use of systemic steroids or immunosuppressive medications.\n* Known bleeding disorders or anticoagulant therapy.\n* Pregnancy or lactation.\n* Severe psychiatric or cognitive disorders.\n* Any Congenital or Non-congenital disorders","30 Years","70 Years",{"count":21,"type":22},[54],"EARLY_PHASE1","This clinical trial aims to check the safety and efficacy profile of pulsed radiofrequency (RF) neuromodulation combined with leukocyte-rich platelet-rich plasma (PRP) injections for the treatment of refractory low back pain due to multifidus dysfunction. The trial will compare two groups: one receiving standard physical therapy and the other receiving pulsed RF neuromodulation and physiotherapy.",[57],"Multi-Organ Disorder","2024-09-02",{"date":32,"type":33},{"date":61,"type":33},"2024-07-10",{"date":63,"type":22},"2025-12-30",{"name":39,"class":40},{"id":66,"slug":67,"hasResults":11,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":71,"eligibilityCriteria":72,"healthyVolunteers":73,"sex":17,"minAge":74,"maxAge":75,"enrollmentInfo":76,"targetDuration":4,"studyType":23,"phases":77,"briefSummary":78,"conditions":79,"keywords":81,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":84,"startDateStruct":86,"completionDateStruct":87,"leadSponsor":89,"locationsCount":41},"100550915","assessment-of-different-clinical-techniques-to-treat-patients-with-chronic-low-back-pain-100550915","NCT06453291","Assessment of Different Clinical Techniques to Treat Patients With Chronic Low Back Pain","Innovative Approaches in Managing Chronic Low Back Pain: A Comparative Assessment of Clinical Techniques","CLBP","Inclusion Criteria:\n\n* Adults aged 40-60 years.\n* Diagnosed with chronic low back pain persisting for more than three months.\n* Willingness to participate and comply with study procedures.\n* Ability to provide informed consent.\n\nExclusion Criteria:\n\n* Comorbidities.\n* Contagious and Non-Contagious Infections\n* Known hypersensitivity to study interventions.\n* Presence of severe psychiatric disorders.\n* Pregnancy or breastfeeding.\n* Participation in another clinical trial within the last 30 days.",true,"40 Years","60 Years",{"count":21,"type":22},[25],"This clinical trial aims to assess the effectiveness of different clinical techniques in treating patients with chronic low back pain (CLBP). Two test groups will be included: one receiving conventional therapy (NSAIDs and other physical therapy techniques) and the other receiving a combination of neuromodulation and platelet-rich plasma (PRP) therapy. Chronic pain, persisting for more than three months, inhibits natural pathways like GABA and promotes excitatory pathways, leading to increased inflammation. The study hypothesizes that neuromodulation via the dorsal root ganglion (DRG) and PRP therapy will provide superior pain relief and functional improvement compared to conventional therapy.",[80],"Chronic Low Back Pain (CLBP)",[71,82,83],"Neuromodulation","PRP",{"date":85,"type":33},"2024-09-04",{"date":61,"type":33},{"date":88,"type":22},"2025-05",{"name":39,"class":40},""]